Telo Genomics (TSXV:TELO) Net Change in Cash : C$-2.74 Mil (TTM As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

What is Telo Genomics Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Telo Genomics's Net Change in Cash for the three months ended in Dec. 2023 was C$-0.68 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 was C$-2.74 Mil.

Telo Genomics Net Change in Cash Historical Data

The historical data trend for Telo Genomics's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Telo Genomics Net Change in Cash Chart

Telo Genomics Annual Data

Trend

Dec13

Dec14

Dec15

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Net Change in Cash

Get a 7-Day Free Trial

-0.05

0.90

2.72

-0.94

-0.02

Telo Genomics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Net Change in Cash	Get a 7-Day Free Trial															-0.71	-0.69	-0.67	-0.70	-0.68

Telo Genomics Net Change in Cash Calculation

Telo Genomics's Net Change in Cash for the fiscal year that ended in Jun. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-2.63	+	-0.069	+	2.679	+	0
	=	-0.02

Telo Genomics's Net Change in Cash for the quarter that ended in Dec. 2023

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -0.683 + 0 + 0 + 0

= -0.68

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-2.74 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Telo Genomics Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Telo Genomics's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Telo Genomics (TSXV:TELO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Telo Genomics Corp (TSXV:TELO) » Definitions » Net Change in Cash

Comparable Companies

XCNQ:SONA TSXV:AVCR XCNQ:IZO XCNQ:BUX TSXV:ARC TSX:SZLS TSXV:JUMP XCNQ:VTAL NEOE:MEDV TSXV:MBI.H TMO DHR SHSE:603259 IDXX IQV A XSWX:LONN MTD ICLR ILMN

Traded in Other Exchanges

TDSGF:USA 3D0A:Germany

Address

101 College Street, Suite 200, MaRS Centre, South Tower, Toronto, ON, CAN, M5G 1L7

Website

https://www.telodx.com

Telo Genomics Corp is a personalized medicine company. The company through its wholly-owned subsidiary is engaged in the development and commercialization of diagnostic and prognostic products. The company is developing diagnostic and prognostic products for cancer and neurological disorders.

Telo Genomics (TSXV:TELO) Headlines

From GuruFocus

UPDATE -- Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in Canines
By GlobeNewswire • 03-29-2024